Jianjun Zou

Jiangsu Hengrui Medicine Co., Ltd.

Shanghai

China

SCHOLARLY PAPERS

1

DOWNLOADS

42

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Pyrotinib or Lapatinib Combined with Capecitabine in Women with HER2-Positive Metastatic Breast Cancer Previously Treated with Taxanes, Anthracyclines, And/Or Trastuzumab: An Open-Label, Randomised, Phase 2 Study

Number of pages: 111 Posted: 22 Nov 2018
Chinese Academy of Medical Sciences - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Chinese Academy of Medical Sciences - Peking Union Medical College, Jilin University (JLU) - First Affiliated Hospital, Academy of Military Sciences - Academy of Military Medical Sciences, Tianjin Medical University, Hebei Medical University, Peking University - Cancer Hospital and Institute, Huazhong University of Science and Technology (Formerly Tongi Medical University), Jiangsu Cancer Hospital - Department of Medical Oncology, Sun Yat-Sen University (SYSU) - Cancer Center, Fudan University - Shanghai Cancer Center (FUSCC), Jiangsu Hengrui Medicine Co., Ltd. and Jiangsu Hengrui Medicine Co., Ltd.
Downloads 42 (444,463)
Citation 1

Abstract:

Loading...

Pyrotinib, lapatinib, HER2-positive metastatic breast cancer